Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference
Although PD-L1 testing is standard in some cases, many patients end up on Keytruda without really benefiting,” said Faith Zaslavsky, CEO of Ignite Proteomics and IMAC Holdings. “Our analysis shows ...
Ignite Proteomics presents data on MHC-II as predictor of pembrolizumab response
Ignite Proteomics announced the presentation of new data demonstrating that MHC-II protein expression is a superior predictor of response to ...
Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay
Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of Proprietary Laboratory Analyses (PLA) code 0249U – originally issued to Theralink ...
Nasdaq5d
Ignite Proteomics LLC Completes Transfer of PLA Code 0249U to Enhance Breast Cancer Diagnostic Capabilities
Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc., has successfully transferred the Proprietary Laboratory Analyses (PLA) code 0249U from Theralink Technologies, allowing recognition and ...
Morningstar5d
Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay
Golden, CO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of Proprietary Laboratory Analyses ( ...
Nasdaq5d
Ignite Proteomics Completes Acquisition Of PLA Code 0249U For Proteomic Breast Cancer Assay
(RTTNews) - Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (BACK), on Wednesday announced the successful acquisition of Proprietary Laboratory Analysis or PLA code 0249U, initially ...
Mena FN5d
Ignite Proteomics Completes Acquisition Of PLA Code 0249U For Its Advanced Proteomic Breast Cancer Assay
(MENAFN- GlobeNewsWire - Nasdaq) Golden, CO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of ...
Morningstar14d
Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response
Golden, CO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), announces the publication of a significant study in the British Journal of ...